Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

Combined treatment with olmesartan medoxomil and amlodipine besylate attenuates atherosclerotic lesion progression in a model of advanced atherosclerosis

Philipp Sievers,1 Lorenz Uhlmann,2 Sevil Korkmaz-Icöz,3 Christian Fastner,1 Florian Bea,1 Erwin Blessing,1 Hugo A Katus,1 Michael R Preusch11Department of Internal Medicine III, 2Institute of Medical Biometry and Informatics, 3Department of Cardiac Surgery, University of H...

Full description

Bibliographic Details
Main Authors:	Sievers P, Uhlmann L, Korkmaz-Icöz S, Fastner C, Bea F, Blessing E, Katus HA, Preusch MR
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-07-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/combined-treatment-with-olmesartan-medoxomil-and-amlodipine-besylate-a-peer-reviewed-article-DDDT

Similar Items

Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study
by: Zhaoqiang Cui, et al.
Published: (2024-01-01)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016-08-01)

Critical appraisal of amlodipine and olmesartan medoxomil fixed-dose combination in achieving blood pressure goals
by: Jan Basile
Published: (2010-06-01)

Safety and tolerability of fixed antihypertensive combinations in blood pressure control: focus on olmesartan medoxomil and amlodipine combination
by: Ijlal Uddin, et al.
Published: (2010-11-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
by: R. P. Mason
Published: (2012-06-01)

Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
by: Mason
Published: (2011-06-01)

Bioequivalence evaluation of two amlodipine salts, besylate and orotate, each in a fixed-dose combination with olmesartan in healthy subjects
by: Lee SY, et al.
Published: (2015-06-01)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
by: Mark Greathouse
Published: (2006-12-01)

Inclusion complexes of amlodipine besylate and cyclodextrins
by: Kapor Agneš, et al.
Published: (2010-08-01)

EVALUATION OF ANTIHYPERTENSIVE THERAPY WITH THE COMBINATION OF OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
by: Steven G. Chrysant, et al.
Published: (2011-06-01)

Olmesartan medoxomil: current status of its use in monotherapy
by: Hans R Brunner
Published: (2006-12-01)

Synthesis of related substances of olmesartan medoxomil, an anti-hypertensive drug
by: Karrothu S. Babu, et al.
Published: (2010-05-01)

FORMULATION AND EVALUATION OF S-(-)-AMLODIPINE BESYLATE AND NEBIVOLOL HYDROCHLORIDE TABLETS
by: Shaikh S.A, et al.
Published: (2010-06-01)

Design of Olmesartan Medoxomil-Loaded Nanosponges for Hypertension and Lung Cancer Treatments
by: Bjad K. Almutairy, et al.
Published: (2021-07-01)

EFFECT OF ANGIOTENSIN RECEPTOR BLOCKADE ON ENDOTHELIAL FUNCTION: FOCUS ON OLMESARTAN MEDOXOMIL
by: C. Ferrario
Published: (2010-12-01)

Olmesartan medoxomil-loaded mixed micelles: Preparation, characterization and in-vitro evaluation
by: Mohamed A. El-Gendy, et al.
Published: (2017-12-01)

Effect of angiotensin receptor blockade on endothelial function: focus on olmesartan medoxomil
by: Carlos Ferrario
Published: (2009-03-01)

Amlodipine Besylate has no Adverse Effect on Male Hormonal Profile
Published: (2016-11-01)

Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
by: Rania Moataz El-Dahmy, et al.
Published: (2023-03-01)

PROTECTIVE EFFECTS OF ANGIOTENSIN II BLOCKADE WITH OLMESARTAN MEDOXOMIL ON RESISTANCE VESSEL REMODELING
by: Ronald D. Smith, et al.
Published: (2010-10-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

Stability-indicating comparative methods using mekc and lc for determination of olmesartan medoxomil
by: Lisiane Bajerski, et al.
Published: (2013-01-01)

Combination Therapy with Olmesartan and Amlodipine in the Treatment of Hypertension
by: Menco G. Niemeijer, et al.
Published: (2009-12-01)

A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
by: Blank, R, et al.
Published: (2007)

Kinetic spectrophotometric method for determination of amlodipine besylate in its pharmaceutical tablets
by: Ashraf M. Mahmoud, et al.
Published: (2012-10-01)

Development and validation of stability-indicating RP-HPLC method for determination of Olmesartan medoxomile in pharmaceutical dosage form and identification, characterization of alkaline degradation impurity of Olmesartan medoxomile drug substance as well as drug product
by: Jain P.S., et al.
Published: (2012-01-01)

Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study
by: Vivencio Barrios, et al.
Published: (2009-08-01)

Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice
by: Zhu Y, et al.
Published: (2019-10-01)

Method development for simultaneous estimation of Amlodipine Besylate and Perindopril Tertbutyl amine in fixed-dose
by: Muhammad Farooq Saleem Khan, et al.
Published: (2023-03-01)

Efficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)
by: Richard Buendia, et al.
Published: (2017-04-01)

Olmesartan/amlodipine: a review of its use in the management of hypertension
by: Kreutz R
Published: (2011-03-01)

Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
by: Mac Arturo Murillo-Fernández, et al.
Published: (2022-02-01)

A novel nano-formulation of olmesartan medoxomil with improved delivery and efficacy in the treatment of indomethacin-induced duodenitis in rats
by: H.A. Murad, et al.
Published: (2023-05-01)

ANTIHYPERTENSIVE EFFICACY AND SAFETY OF OLMESARTAN MEDOXOMIL AND RAMIPRIL IN ELDERLY PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION: THE ESPORT STUDY
by: E. Malacco, et al.
Published: (2012-02-01)

Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy
by: Shengfu Jiao, MB, et al.
Published: (2022-04-01)

Integrated Quality by Design Approach for Developing Nanolipidic Drug Delivery Systems of Olmesartan Medoxomil with Enhanced Antihypertensive Action
by: Jagdish Kumar Arun, et al.
Published: (2020-05-01)

High throughput microwell spectrophotometric assay for olmesartan medoxomil in tablets based on its charge-transfer reaction with DDQ
by: Darwish Ibrahim A., et al.
Published: (2014-03-01)

Efficacy and tolerability between an olmesartan/amlodipine fixed-dose combination and an amlodipine double dose in mild to moderate hypertension
by: Tsung-Hsien Lin, et al.
Published: (2013-05-01)

Improved oral absorption of cilostazol via sulfonate salt formation with mesylate and besylate
by: Seo JH, et al.
Published: (2015-07-01)

Development of dissolution test method for a telmisartan/amlodipine besylate combination using synchronous derivative spectrofluorimetry
by: Panikumar Durga Anumolu, et al.
Published: (2014-04-01)